Lantheus Q2 revenue $388.2M, EPS $1.11; suspends FY2026 guidance due to pending Curium merger

Lantheus Holdings, Inc.

Worldwide revenue $388.2M, up 2.7% YoY; GAAP EPS $1.11 vs $1.12; adjusted EPS $1.55 vs $1.57.
PYLARIFY sales $240.4M (-4.1% YoY); DEFINITY $88.3M (+5.2%); Neuraceq $39.6M.
Operating income $100.2M (+13.9%); adjusted operating income $142.0M (-6.9%).
Company suspends FY2026 guidance and will not hold Q2 call due to pending $8.0B Curium merger (announced Aug 3).
Cash and equivalents $593.3M at June 30, 2026; access to $750M revolver.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.